Vascular endothelial growth factor polymorphisms (−460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression Raúl Cosín, B.S., Juan Gilabert-Estellés, M.D., Ph.D., Luis A. Ramón, B.S., Francisco España, Ph.D., Juan Gilabert, M.D., Ph.D., Alberto Romeu, M.D., Ph.D., Amparo Estellés, M.D., Ph.D. Fertility and Sterility Volume 92, Issue 4, Pages 1214-1220 (October 2009) DOI: 10.1016/j.fertnstert.2008.08.079 Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions
Figure 1 Vascular endothelial growth factor (VEGF) in patients and controls. (A) VEGF antigenic (Ag) levels in endometrial tissue extracts. (B) VEGF mRNA levels [100x(VEGF mRNA copies/β-actin mRNA copies)] in endometrial tissue extracts. (C) VEGF antigenic (Ag) levels in peritoneal fluid. Data are expressed as mean ± standard error of the mean. Fertility and Sterility 2009 92, 1214-1220DOI: (10.1016/j.fertnstert.2008.08.079) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions
Figure 2 Vascular endothelial growth factor (VEGF) in patients and controls according to VEGF polymorphisms. (A) VEGF antigenic (Ag) levels in endometrial tissue extracts. (B) VEGF mRNA levels [100x(VEGF mRNA copies/β-actin mRNA copies)] in endometrial tissue extracts. (C) VEGF antigenic (Ag) levels in peritoneal fluid. Data are expressed as mean ± standard error of the mean. Fertility and Sterility 2009 92, 1214-1220DOI: (10.1016/j.fertnstert.2008.08.079) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions